MoonLake Immunotherapeutics (MLTX)
| Market Cap | 184.26M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -69.45M |
| Shares Out | 36.93M |
| EPS (ttm) | -0.31 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 52,997 |
| Open | 5.23 |
| Previous Close | 5.29 |
| Day's Range | 4.82 - 5.68 |
| 52-Week Range | 4.25 - 15.19 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About MLTX
As of April 5, 2022, Helix Acquisition Corp. was acquired by MoonLake Immunotherapeutics AG, in a reverse merger transaction. Helix Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses or entities. The company was founded in 2020 and is based in Boston, Massachusetts.
Financial Performance
Financial StatementsNews
MoonLake Immunotherapeutics starts Phase 2 trial of the Nanobody® Sonelokimab in patients with moderate-to-severe hid...
MoonLake Immunotherapeutics starts Phase 2 trial of the Nanobody® Sonelokimab in patients with moderate-to-severe hidradenitis suppurativa
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Merger of He...
New York, New York--(Newsfile Corp. - October 4, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All Persons or Entities who purchased Helix Acquisition Corp. (NASDAQ: HLXA...
MoonLake Immunotherapeutics AG and Helix Acquisition Corp. Announce Business Combination Agreement to Create Publicly...
ZUG, Switzerland & BOSTON--(BUSINESS WIRE)--MoonLake Immunotherapeutics AG, a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory skin and joint diseases and H...
Helix Acquisition Corp. Announces Closing of $115 Million Initial Public Offering, Including the Full Exercise of the...
Boston, Massachusetts--(Newsfile Corp. - October 22, 2020) - Helix Acquisition Corp. (NASDAQ: HLXA) (the "Company") announced today that on Oct. 22, 2020 it closed its initial public offering of 11,500,...
Helix Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering
Boston, Massachusetts--(Newsfile Corp. - October 19, 2020) - Helix Acquisition Corp. (the "Company") announced today that it priced its initial public offering of 10,000,000 Class A ordinary shares at $...